| Term 
 
        | Any Asthma patient needs influenza and pneumococcal shot True/False? Patient should be treated for rhinitis, sinusitis and GERD if present T/F? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NAME THREE QUICK RELIEF MEDICATIONS |  | Definition 
 
        | 1. Albuterol and other short acting Beta2 Agonist. 2- Short acting Acetylcholine Agonist.  3-Systemtic Corticosteriod  |  | 
        |  | 
        
        | Term 
 
        | Name the 6 Medications used for Long term CONTROL |  | Definition 
 
        | 1. inhaled corticosteriod- cornerstone of long term asthma 2. Long acting BETA2 agonist 3. leukotriene receptor modifiers 4. theophylline 5. IgE Inhibitor 6. Mast Cell Modifier   |  | 
        |  | 
        
        | Term 
 
        | Managing ACUTE EXCERBATION of asthma has three goals: 1- Correction of significant HYPOXEMIA 2- Rapid reversal of airflow obstruction 3- Reduce recurrence of severe obstruction 4- reduce morbidity and mortality Explain how to assess severity of acute excerbation of asthma at home- |  | Definition 
 
        | 1. Measure PEAK EXPIRATORY FLOW: if less than 80% then it suggests severe exacerbation. Note the signs and symptoms such as degree of cough, breathlessness, wheezing and cheat tightness. Initial treatment of SABA; three treatments of 2-4 puffs by MDI at 20mins intervals or single nebulizer treatment.  
 |  | 
        |  | 
        
        | Term 
 
        | After the Intitial treatment patient usually does a PEF and finds percent of best. Explain the three possible findings and treatment (home). >80%  50%-80%  <50% |  | Definition 
 
        | 1.   >80% is a mild exacerbation, usually no wheezing or SOB. Responses to Beta2 agonist sustained for 4 hrs. Continue using b2 agonist every 3-4hrs for 48hrs.  -call MD for follow up 2-    50%-80% moderate exacerbation  usually with persistent wheeze or SOB. Add oral corticosteroids (short burst) and continue the use of b2 agonist. Call MD for more urgent follow up.  3.  <50% is severe exacerbation, marked wheezing or SOB. Add oral corticosteroid (short burst) and repeat beta agonist immediately. CALL MD AND GO TO ER.  |  | 
        |  | 
        
        | Term 
 
        | 1- what is the dose of Prednisone, Methylprednisolone and Prednisolone  2- how is corticosteroid dosed?   |  | Definition 
 
        | 1- 120- 180 mg/day divided doses for 48hrs, then 60-80 mg/day until PEF reachest 70%. 2. Dosed 1mg-2mg per Kg per day.      remember this is dosages for drugs for acute asthma exacerbation in ER or hospital.  |  | 
        |  | 
        
        | Term 
 
        | Patient: suffering form 4 night awakings a month due to shortness of breath and less than 2 days in a week of using the SABA, still runs daily, and has a FEV1 of 75%. Currently on low dose ICS, ASSESS! |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | list the symptoms, nighttime awakenings, SABA use (frequency), and Lung Function (FEV1 or PEF%)  for Intermittent and MILD MODERATE AND SEVERE PERSISTENT |  | Definition 
 
        | intermittent- Symp less than 2d/week, Nightwake less than 2xmonth, SABA use Less than 2d/week, Lung function greater than 80% Mild- symp more than 2 days a week but not daily, nightwake- 3-4x month, SABA use >2days/weeek/ not daily. greater than 80% PEF 
 Moderate- daily symptoms, 1x week night wake, Daily SABA use, PEF 60-80%.  Severe- sympt throughout the day, 7x week nightwake, SABA use throughout the day, PEF less than 60% |  | 
        |  | 
        
        | Term 
 
        | step 1 Intermitten Asthma |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Preferred Low dose ICS with SABA PRN for control of symptoms.  Alternative-  Cromolyn Nedocromil LTRA or Theophylline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Preferred Medium dose ICS  OR Low dose ICS n LABA   with alternatives of low dose ICS and either LTRA or Theophyline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Medium Dose ICS and LABA alternative Medium dose ICS and either LTRA or Theophylline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Preferred High dose ICS and LABA and CONSIDER Omalizumab for patients with allergies! |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Preferred High dose ICS and LABA and ORAL corticosteroids and Consider omalizumab for patients with allergies!  |  | 
        |  | 
        
        | Term 
 
        | if a patient has less than 2 days a week of symptoms and 1-3x a week nighttime awakwenings, uses the SABA about 2/d/week, No interference with Normal activites... with a PEF greater than 80% is this patient controlled? well or not..   |  | Definition 
 
        | Well control= <2day/week symptoms, <2x/month nightwake/ <2days/weekSABA/ No interference with physical activites PEF>80% recommended maintain current step and follow regular checkups 1-6months.  NOT WELL CONTROLLED= >2DAYS/WEEK(NOT DAILY) OF SYMPTOMS, 1-3X WEEK NIGHTWAKE, >2D/WEEK OF SABA USE SOME LIMITATION OF ACTIVITIES, PEF60-80%, CONSIDER SHORTBURST STRERIOD   {STEP UP ONE STEP AND REVALUATE} 
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Symptoms throughout the day nighttime awakingins- 4xweek SABA use several times per day more than 2 days a week. extremely limiting physical activities less than 60% PEF consider short burst oral corticosteroid  STEP UP 2 STEPS AND REEVALUATE IN 2-6 WEEKS.  |  | 
        |  | 
        
        | Term 
 
        | ICE? BEFORE CHANGING THERAPY, NEED TO ASSESS OTHER REASONS FOR POOR ASTHMA CONTROL.  |  | Definition 
 
        | I-INHALED COMPLIANCE C- COMPLIANCE E- ENVIROMENTAL CHANGE   |  | 
        |  | 
        
        | Term 
 
        | B2 SELECTIVE AGONIST SHORT ACTING!! I WANT ROUTE, ONSET and DOA |  | Definition 
 
        | 1-albuterol- PO-30mins onset, 4-8 DOA INH- 5mins onset, 3-6 DOA.  2. Bitolterol- INH less than 5min Onset and 4-8 DOA  3. Levabuterol- INH less than 5min onset with 3-6hr DOA 4. Pirbuterol INH less than 5min Onset with 4-8hr DOA 5. Terbutaline- PO<30mins Onset 4-8DOA SC<15mins onset 2-4 DOA INH<5mins Onset 3-6 DOA     |  | 
        |  | 
        
        | Term 
 
        | Long acting Beta 2 selective agonist Route- onset- DOA and Dosage |  | Definition 
 
        | Formoterol (foradil) DPI 5min onset with 12hr DOA Salmeterol- (Serevent) DPI <30mins onset and12hr DOA |  | 
        |  | 
        
        | Term 
 
        | What are some Adverse Effects of Beta agonist   |  | Definition 
 
        | increase HR can cause tremmors, Shakiness, Can cause low potassium ( usually with PO or SUBQ)(this low K is probably due to a shift in the potassium from out to into the cell) monitor for hypokalemia.  |  | 
        |  | 
        
        | Term 
 
        | How would one monitor for  1. Efficacy 2. Toxicity  with Beta 2 Blockers! |  | Definition 
 
        | 1- Efficacy monitor Peak Flow , signs and symptoms and usage of SABA.  2. Toxicity- Heart rate, tremors, and K if its PO  or SQ.  |  | 
        |  | 
        
        | Term 
 
        | Mast Cell stabilizers!  name- indications, and AE |  | Definition 
 
        | Cromolyn (intal)- MDI, DPI, nebulized solution Nedocromil (Tilade)- MDI indications- long term prevention of symptoms, prevention of allergen induced bronchospasm and exercse induced asthma, response seen in 2 weeks but 4-6 for maximal benefits. disadvantage- need to be dosed 3-4times a day.  AE- 15-20% complain of unplesant taste from nedocromil,  preferred over corticosteroids for anti-inflammatory action in children.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Used as anti-Inflammatory Inhaled- long term prevention of symptoms Systemic- short-course burst following an acute exacerbation or to gain quick control of poorly controlled asthma.   systemic for long term prevention (step 6)  |  | 
        |  | 
        
        | Term 
 
        | what are the Adverse Effects of Inhaled and systemic corticosteriods |  | Definition 
 
        | inhaled- cough, dysphonia, oral thrust ( candidiasis)  Systemic- increase glucouse and appetite, some fluid retention, weight gain, mood alteration and even hypertension and peptic ulcer , with long term use.. adrenal axis suppression, growth suppression, cushin syndrome, osteoporosis and muscle weakness.  |  | 
        |  | 
        
        | Term 
 
        | 8 Corticosteriods, name them and long medium and high dose!   |  | Definition 
 
        | Beclomethasone (Qvar) HFA(40or 80mcg/puff) L-80-240mcg M-240-480mcg H- >480mcg Budesonide (pulmocort)(DPI) 90-180-160mcg/inh L-180-600mcg M-600-1200mcg H->1200mcg Ciclesonide (Alvesco) 80mcg, 160mcg L-80-160mcg M-160mcg-320mcg H>320mcg. Flunisolide (Aerobid) 250mcg/puff L- 500-1000mcg M 1000mcg-2000mcg L- >2000mcg Flunisolide HFA- 80mcg/puff L-320 mcg M 320-640mcg H- >640mcg Fluticasone (flovent) HFA/MDI- 44, 110, L- 220mcg/puff 88-264 M      |  | 
        |  |